There was no interaction observed in relation to disease risk, when considering ER+ breast cancer (pint = 0.98), or overall breast disease risk (pint = 0.47), and no effect heterogeneity was found when comparing the risk of ER– and ER+ breast cancer (phet = 0.99). Here, ESR1 is linked to breast carcinoma.